Award
NIH Reporter #5R01CA286918-02
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
Recipient
SLOAN-KETTERING INST CAN RESEARCH
Award Amount
$715,058.00
Ceiling
$715,058.00
Awarded
June 24, 2025
Identifier
5R01CA286918-02
Award for research on DLL3-targeting agents for lung and prostate neuroendocrine carcinomas, focusing on diagnostic imaging and targeted radiotherapy.
Description
This project involves evaluating the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate, including diagnostic imaging and targeted radiotherapy.